开放获取期刊获得更多读者和引用
700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
Lin Xu
In chronic kidney disease (CKD) patients, vascular calcification (VC) and cardiac valve calcification (CVC) are the major reasons of increased risk of cardiovascular events. Originally thought to be a passive kind of dead or dying cells, VC and CVC have since been identified as a disease caused by an active and highly controlled cellular process. Several of the processes implicated in VC have recently been identified, and many of them may be exacerbated in CKD patients. FGF-23/Klotho axis, Wnt pathways, PI3K/Akt signalling, P38MAPK signalling pathway, and microRNAs, in particular, have been demonstrated to be disturbed in CKD patients and may have a role in vascular calcification. Moreover, multiple researches confirmed the hazards of CVC in CKD patients as well as the molecular processes behind it. The purpose of this review is to describe the risk variables and pathophysiological processes that may be implicated in the relationship among CKD and VC and CVC development.